drugset / Trial / NCT01244971

Exercise and Acarbose in Type 2 Diabetes

NCT01244971

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the impact of exercise training, Acarbose, and the combination of exercise and Acarbose on glycemic control, body composition, insulin sensitivity and other cardiovascular risk markers in type 2 diabetes. Further, muscle biopsies will be obtain to study gene expression. Our hypothesis is that the combination therapy will be superior to monotherapy with exercise or Acarbose.

Timeline

Start
2004-01
Primary completion
2004-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acarbose Unknown 100 mg